The Structural Disease Center

Filter Your Results

 

News

 

Results Presented From REDUCE Study of Gore's Cardioform for PFO Closure

May 16, 2017 -- Gore & Associates announced positive results from the company's REDUCE study assessing closure of patent foramen ovale (PFO) for the reduction of recur…

European Registry Results Presented for Boston Scientific's Watchman LAAC Device

May 12, 2017 -- Boston Scientific Corporation announced positive safety and efficacy rates of the Watchman left atrial appendage closure device from the EWOLUTION registry, wh…

Study Evaluates Feasibility of Closure for Hemodynamically Significant Patent Ductus Arteriosus

May 8, 2017 -- In a study published online in Catheterization and Cardiovascular Interventions, Patrice Morville, MD, and Ahmad Akhavi, MD, concluded that it is feasible to cl…

Occlutech's PmVSD Occluder Obtains CE Mark Approval

April 11, 2017 -- Occlutech recently announced that it has obtained European CE Mark approval for its perimembranous ventricular septal defect (PmVSD) occluder. Occlutech…

Boston Scientific Agrees to Acquire Symetis

March 30, 2017 -- Boston Scientific Corporation announced a definitive agreement to acquire Symetis SA, a privately-held structural heart company based in Switzerland that is …

LASSO-AF Clinical Trial Approved for Aegis Medical Innovations' Sierra Ligation System

March 22, 2017 -- Aegis Medical Innovations Inc. announced that it has received investigational device exemption approval from the US Food and Drug Administration to init…

Closing Left Atrial Appendage Shown to Reduce Stroke Risk From Atrial Fibrillation

March 19, 2017 -- For patients with atrial fibrillation (AF), closing the left atrial appendage as an add-on procedure during cardiac surgery was associated with a 40% reducti…

An Interview With Josep Rodés-Cabau, MD

January/February 2017—Dr. Rodés-Cabau discusses the current landscape of transcatheter valve technologies, as well as his participation in innovative structural heart interventions.

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.